Feb 7th 2023 - Mar 21st 2023
And we are just thrilled to move this forward and ... See more
And we are just thrilled to move this forward and ... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$OCGN Bla is better than eua.
We get government funding- we execute atm funding ... See more
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
Niydad might be a tasty accretive buy, with EUA likely in 2023, etc.
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA (Emergency Use Authorization).
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA (Emergency Use Authorization).
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
And we are just thrilled to move this forward and really help these patients out, hopefully with that EUA.
But when it hits here EUA is a shoe in.
If EUA thumbs up by FDA.
$EDSA Drop the EUA BOMB 💣.
EUA APPROVAL SHOCKER $50-$100 GL! 🤑
EUA any day… So glad I’m not short AND have my biggest position here than EVER before.
What I love about this stock is the probability of EUA Filing and the fact WE DON'T HAVE TO WAIT FOR FDA APPOVAL IF EU, THE STOCK WILL EXPLODE ON THE FILING ALONE!
$OCGN Bla is better than eua.
We get government funding- we execute atm funding - NeoCart phase 3 trials and EuA for nasal vaccine for Usa Europe and japan - I feel extra bullish after AstraZeneca fails nasal vaccine trials.
